MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 50 filers reported holding MIRATI THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,000 | -88.4% | 100 | -92.9% | 0.00% | -87.5% |
| Q1 2018 | $43,000 | +126.3% | 1,400 | +33.3% | 0.01% | +166.7% |
| Q4 2017 | $19,000 | +58.3% | 1,050 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $12,000 | -45.5% | 1,050 | -82.6% | 0.00% | -50.0% |
| Q2 2017 | $22,000 | -29.0% | 6,050 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $31,000 | +6.9% | 6,050 | 0.0% | 0.01% | -28.6% |
| Q4 2016 | $29,000 | -27.5% | 6,050 | 0.0% | 0.01% | -36.4% |
| Q3 2016 | $40,000 | +21.2% | 6,050 | 0.0% | 0.01% | +22.2% |
| Q2 2016 | $33,000 | -69.2% | 6,050 | +21.0% | 0.01% | -76.3% |
| Q1 2016 | $107,000 | -31.8% | 5,000 | 0.0% | 0.04% | -32.1% |
| Q2 2015 | $157,000 | +6.8% | 5,000 | 0.0% | 0.06% | -1.8% |
| Q1 2015 | $147,000 | +162.5% | 5,000 | +66.7% | 0.06% | +137.5% |
| Q4 2014 | $56,000 | +5.7% | 3,000 | 0.0% | 0.02% | -7.7% |
| Q3 2014 | $53,000 | – | 3,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |